Fabtech Q2 FY27: revenue down 24%, PAT down 47% after one-off gain
FABTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.8 pts less than Nifty Microcap 250 and 3.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved unaudited consolidated and standalone results for Q2 and H1 FY27; the auditor's review was unmodified. Q2 revenue Rs 9,208.76 lakh, down 24.2% from Rs 12,148.07 lakh. Net profit Rs 1,502.48 lakh, down 46.5%, helped by a Rs 835.25 lakh exceptional gain on selling its TSA stake to Thermax. H1 revenue Rs 16,707.17 lakh, down 11.8%; profit Rs 1,923.51 lakh; operating cash flow negative Rs 4,114.28 lakh.
Q2 revenue and profit fell sharply; the one-off gain cushioned PAT. Negative operating cash flow and weaker sales could weigh on the stock.